Article
Engineering a Dimeric Single-Domain Antibody for Improved Detection and neutralization of Amyloid-β Oligomers
2025-08-31
Abstract excerpt
Soluble Aβ oligomers are regarded as major neurotoxic agents in Alzheimer’s disease. Several monoclonal antibodies have been developed to target Aβ oligomers, but most of them show limited specificity binding also to monomers and fibrils. To generate an antibody with high specificity for the oligomers, we aimed to increase the efficiency and sensitivity of a humanized Aβ-oligomer-specific single domain antibody, c...
Topics
Open a Topic to create a Post that cites this publication.
- Alzheimer's disease research and treatments
- Cellular transport and secretion
- Cholinesterase and Neurodegenerative Diseases
- Computational Drug Discovery Methods
- Drug Transport and Resistance Mechanisms
- Glycosylation and Glycoproteins Research
- Monoclonal and Polyclonal Antibodies Research
- Protein Structure and Dynamics
Identifiers and source
- Literature Corpus work
- 256061eb-2654-57fc-b1fc-4d5102d4bb4c
- DOI
- 10.1101/2025.08.29.672921
